N/A
Completed N=94,321
Influenza Vaccination Digital Interventions for People Living With Diabetes
Source: ClinicalTrials.gov NCT03870997 ↗Enrolled (actual)
94,321
Serious AEs
—
Results posted
Jun 2020
Primary outcomePrimary: Number of Participants With Self-reported Influenza Vaccination in People With Diabetes — 3310; 1848; 3220; 2051 Participants
Summary
The overall objective of this prospective randomized controlled study is to assess and quantify the impact of digital interventions to increase vaccination rates and vaccination-related outcomes in a connected population with self-reported diabetes. The digital intervention will be delivered via a campaign sent to participants, with interventions varying with each study arm. Participants will be blinded to study participation status.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Self-reported Influenza Vaccination in People With Diabetes |
3310; 1848; 3220; 2051 | — |
Eligibility Criteria
Inclusion Criteria
- At least 18 years old
- Lives in the U.S.
Exclusion Criteria
- < 18 years old
- Does not live in the U.S.
Data sourced from ClinicalTrials.gov (NCT03870997). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.